Engineered immune cells called CAR-T cells are used in the treatment of cancer. Researchers from Uppsala University have now ...

T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new ...

Chimeric antigen receptor-T (CAR-T) cell therapy, initially successful in hematologic malignancies, presents a promising avenue for treating solid tumors, including CRC. This review explores the ...

Giving an additional receptor to T cells that might already be targeting cancer naturally might also “over-activate” those cells, leading to quicker exhaustion of immune cells. Or trogocytosis ...

Scientists from the University of Pennsylvania have developed an innovative cancer treatment using small extracellular ...

Get Instant Summarized Text (Gist) The inflammasome, a group of immune proteins, can prevent blood stem cells from becoming cancerous by removing specific receptors and inhibiting cancer gene activity ...

An approach using engineered small extracellular vesicles from NK cells to DR5 could be a promising strategy for solid tumors ...

Priya Hays, Hays Documentation Specialists, discusses innovations and advancements in the development of personalized cancer ...

Researchers at the University of Pennsylvania have introduced lab-engineered small extracellular vesicles to target tumors in ...